Related Experiment Video
Updated: Aug 14, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
[Acute leukemia in childhood]
Abstract:
Acute leukemias account for one third of all childhood malignancies. The incidence of acute lymphoblastic leukemias (ALL) is 5 times greater than that of acute non-lymphoblastic leukemias (ANLL). Presenting symptoms of acute leukemias reflect bone marrow failure (anemia, bleeding, infections). Diagnostic procedures are extensive (cytology, cytochemistry, immunophenotyping, cytogenetics, molecular biology). Therapy schedules are adapted in respect to individual risk factors. Two thirds of children with ALL are cured. A general reduction of treatment intensity is not possible. Only the radiotherapy of the CNS could be reduced within the last years. Remission induction failures and relapses are the main problems in the treatment of ANLL. One third of the children with ANLL are cured. Because of their worse prognosis infant leukemias represent a special problem.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...